An in-depth look to POLARIS AI PHARMA operating, investing, and financing activities

041910 free cash flow for Q3 24 is 995.69 M KRW. For 2023, 041910 free cash flow was 4.5 B KRW and operating cash flow was 5.53 B KRW.